Enhanced Impact Factor scores observed in Bentham Science publications
Bentham Science Journals See Significant Impact Factor Increases in 2020
Bentham Science, a leading publisher of scientific research, has announced that 35 out of 40 of its journals have secured higher Impact Factors in the 2020 Journal Citation Reports® published by Clarivate.
The list of all Bentham's Impact Factor journals includes:
- Current Gene Therapy
- Current Neuropharmacology
- Recent Patents on Anti-Cancer Drug Discovery
- [Other journals...]
Among these, Current Gene Therapy and Recent Patents on Anti-Cancer Drug Discovery have shown appreciable increases in their Impact Factors. Current Gene Therapy's Impact Factor rose to 4.391, while Recent Patents on Anti-Cancer Drug Discovery's Impact Factor increased to 4.169.
Current Neuropharmacology, which already held a high Impact Factor of 4.668 in the previous period, saw a significant increase, reaching an impressive 7.363 in 2020, making it the highest Impact Factor among Bentham Science journals.
Bentham Science, known for its commitment to publishing impactful research, has expressed its congratulations to its contributors. However, the publisher has not yet revealed specific details on how it plans to raise the bar on publishing in the future.
The publisher aims to benefit the global scientific community by providing a platform for the dissemination of groundbreaking research. Bentham Science encourages researchers to continue submitting their work to its journals, with the promise of rigorous peer review and wide readership.
Read also:
- Strategic approaches to drastically decrease single-use plastic in healthcare by the year 2040, as outlined in a recent publication.
- Experimental Studies in Developing Toxicological Methods and Models
- Quantum Connections Revealed: Exploring Psychic Phenomena Within a Quantum Framework
- Speech Dereverberation via Coherent to Diffuse Power Ratio Estimators (CDR)
